Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Altimmune (ALT) Depreciation & Amortization - Total (2016 - 2017)

Altimmune (ALT) has disclosed Depreciation & Amortization - Total for 6 consecutive years, with $33007.0 as the latest value for Q1 2017.

  • Quarterly Depreciation & Amortization - Total fell 12.45% to $33007.0 in Q1 2017 from the year-ago period, while the trailing twelve-month figure was $33007.0 through Dec 2017, down 76.99% year-over-year, with the annual reading at $143437.0 for FY2016, 1.29% up from the prior year.
  • Depreciation & Amortization - Total for Q1 2017 was $33007.0 at Altimmune, roughly flat from $33066.0 in the prior quarter.
  • The five-year high for Depreciation & Amortization - Total was $52602.0 in Q1 2013, with the low at $32235.0 in Q3 2016.
  • Average Depreciation & Amortization - Total over 5 years is $38264.3, with a median of $37106.0 recorded in 2015.
  • The sharpest move saw Depreciation & Amortization - Total crashed 38.45% in 2013, then increased 10.22% in 2016.
  • Over 5 years, Depreciation & Amortization - Total stood at $43438.0 in 2013, then fell by 15.54% to $36686.0 in 2014, then dropped by 10.58% to $32806.0 in 2015, then rose by 0.79% to $33066.0 in 2016, then decreased by 0.18% to $33007.0 in 2017.
  • According to Business Quant data, Depreciation & Amortization - Total over the past three periods came in at $33007.0, $33066.0, and $32235.0 for Q1 2017, Q4 2016, and Q3 2016 respectively.